查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356675

血栓管理設備市場報告：2030 年趨勢、預測與競爭分析

Clot Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

血栓管理設備趨勢與預測

到 2030 年，全球血栓管理設備市場預計將達到 25 億美元，2024 年至 2030 年年複合成長率為 5.2%。該市場的主要促進因素是心血管疾病盛行率的上升和患病高齡化、對微創手術的意願以及技術的不斷進步。全球血栓管理設備市場前景廣闊，診斷中心和醫院市場存在商機。

血栓管理設備市場洞察

根據 Lucintel 的預測，神經血管栓塞裝置預計將在預測期內實現最高成長，因為它們可用於治療主要發生在腦血管中的栓塞等病變。

由於擴大採用院內專業部門、先進實驗室和手術室進行心血管治療，醫院可能仍然是市場中最大的部分。

由於心血管疾病患病不斷上升以及該地區醫療基礎設施的改善，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球血栓管理設備市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球血栓管理設備市場趨勢（2018-2023）與預測（2024-2030）
  • 全球血栓管理設備市場（按產品）
    • 神經血管栓塞裝置
    • 用於栓塞的球囊導管
    • 經皮栓裝置
    • 導管定向溶栓（CDT）裝置
    • 大靜脈篩檢程式(IVCF)
  • 按經經皮血栓切除設備類型分類的全球血栓管理設備市場
    • 抽吸血栓清除裝置
    • 經皮機械取栓裝置
  • 全球血栓管理設備市場（按最終用途）
    • 診斷中心
    • 醫院
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球血栓管理設備市場（按地區）
  • 北美血栓管理設備市場
  • 歐洲血栓管理設備市場
  • 亞太地區血栓管理設備市場
  • 其他區域血栓管理設備市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球血栓管理設備市場成長機會（按產品）
    • 按經皮血栓切除設備類型分類的全球血栓管理設備市場成長機會
    • 全球血栓管理設備市場成長機會（依最終用途）
    • 全球血栓管理設備市場成長機會（按地區）
  • 全球血栓管理設備市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球血栓管理設備市場的產能
    • 全球血栓管理設備市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes
簡介目錄

Clot Management Devices Trends and Forecast

The future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets. The global clot management devices market is expected to reach an estimated $2.5 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

A more than 150-page report is developed to help in your business decisions.

Clot Management Devices by Segment

The study includes a forecast for the global clot management devices by product, percutaneous thrombectomy devices type, end use, and region.

Clot Management Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices
  • Inferior Vena Cava Filters (IVCF)

Clot Management Devices Market by Percutaneous Thrombectomy Devices Type [Shipment Analysis by Value from 2018 to 2030]:

  • Aspiration Thrombectomy Devices
  • Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Centers
  • Hospitals
  • Others

Clot Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clot Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clot management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clot management devices companies profiled in this report include-

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Clot Management Devices Market Insights

Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Within this market, hospitals will remain the largest segment due to increasing adoption of specialized departments, advanced labs, and operating rooms in hospitals for cardiovascular treatments.

APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Features of the Global Clot Management Devices Market

Market Size Estimates: Clot management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clot management devices market size by product, percutaneous thrombectomy devices type, end use, and region. in terms of value ($B).

Regional Analysis: Clot management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, percutaneous thrombectomy devices types, end uses, and region.s for the clot management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clot management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the clot management devices market size?

Answer: The global clot management devices market is expected to reach an estimated $2.5 billion by 2030.

Q.2. What is the growth forecast for clot management devices market?

Answer: The global clot management devices market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the clot management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

Q.4. What are the major segments for clot management devices market?

Answer: The future of the clot management devices market looks promising with opportunities in the diagnostic centers, and hospitals markets.future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets.

Q.5. Who are the key clot management devices market companies?

Answer: Some of the key clot management devices companies are as follows:

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Q.6. Which clot management devices market segment will be the largest in future?

Answer: Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Q.7. In clot management devices market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clot management devices market by product (neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices,catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF)), percutaneous thrombectomy devices type (aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices), end use (diagnostic centers, hospitals, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clot Management Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clot Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clot Management Devices Market by Product
    • 3.3.1: Neurovascular Embolectomy Devices
    • 3.3.2: Embolectomy Balloon Catheters
    • 3.3.3: Percutaneous Thrombectomy Devices
    • 3.3.4: Catheter-Directed Thrombolysis (CDT) Devices
    • 3.3.5: Inferior Vena Cava Filters (IVCF)
  • 3.4: Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 3.4.1: Aspiration Thrombectomy Devices
    • 3.4.2: Percutaneous Mechanical Thrombectomy Devices
  • 3.5: Global Clot Management Devices Market by End Use
    • 3.5.1: Diagnostic Centers
    • 3.5.2: Hospitals
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clot Management Devices Market by Region
  • 4.2: North American Clot Management Devices Market
    • 4.2.2: North American Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.3: European Clot Management Devices Market
    • 4.3.1: European Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.3.2: European Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.4: APAC Clot Management Devices Market
    • 4.4.1: APAC Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.4.2: APAC Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.5: ROW Clot Management Devices Market
    • 4.5.1: ROW Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.5.2: ROW Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clot Management Devices Market by Product
    • 6.1.2: Growth Opportunities for the Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 6.1.3: Growth Opportunities for the Global Clot Management Devices Market by End Use
    • 6.1.4: Growth Opportunities for the Global Clot Management Devices Market by Region
  • 6.2: Emerging Trends in the Global Clot Management Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clot Management Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clot Management Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: Boston Scientific Corporation
  • 7.3: iVascular SLU
  • 7.4: Teleflex
  • 7.5: Edwards Lifesciences Corporation
  • 7.6: LeMaitre Vascular
  • 7.7: Vascular Solutions
  • 7.8: Straub Medical
  • 7.9: Cook Medical
  • 7.10: DePuy Synthes